Study: Mori 2009, Phytotherapy Research

Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial

Citation

Mori K, Inatomi S, Ouchi K, Azumi Y et al (2009). Phytotherapy Research. PubMed id 18844328.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Lion's mane and reishi mushroom supplements Tier B thin

    B Japanese men and women aged 50 to 80 with mild cognitive impairment (n=30)

    Randomised, double-blind, placebo-controlled trial of lion's mane (Yamabushitake) tablets, 3 g a day for 16 weeks, with 4 weeks of follow-up.

    Cognitive scores rose more in the lion's mane group at weeks 8, 12 and 16, then fell back four weeks after stopping. Laboratory tests showed no adverse effect.

    As recorded in this card: Mori K, Inatomi S, Ouchi K, Azumi Y et al (2009), Phytotherapy Research, [primary]

    Note: 15 people per group. Older Japanese adults with a diagnosed condition, so it says little about healthy people or Black adults.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.